J1448 Trilaciclib - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Trilaciclib

Brand Name:

Cosela

Strength:

1mg

HCPCS:

J1448

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Cyclin Dependent Kinase Inhibitor

Minor Drug Class:

CDK 4/6

Oral (Y/N):

No

FDA Approval Year:

2021

FDA Discontinuation Year:

CMS Effective Date:

Sept. 27, 2021

CMS Discontinuation Date:

Status:

In Use